Global Hematology Leader HORIBA Medical is a global leader in hematology with presence in over 110 countries and a large installed base across more than 300,000 laboratories, indicating strong market reach and potential for cross-sell of diagnostics instruments and consumables.

Expansion Momentum Recent news highlights office expansions in India and growth plans to double India revenue in five years, signaling a focus on emerging markets where there is rising demand for hematology and In Vitro Diagnostics solutions.

R&D Collaboration Partnerships and joint development initiatives, such as Mixing and Dispersion ROPES with Kanazawa University and the University of Tokyo under a NEDO project, point to opportunities for co-development of advanced automated systems and robotics-augmented diagnostics.

Industrial Partnerships Collaborations with global institutions and industry players (e.g., UCL decarbonization chair, Grupo Álava) demonstrate a network-ready position for bundled solutions and services across automotive, materials, and analytical segments that can be extended to healthcare labs seeking robust, scalable instrumentation.

Product & Platform Upsell New product launches such as the CS-900F fiber-optic monitor and combined particle size and shape analyzers expand the portfolio, creating opportunities to upsell upgrades, accessories, and analytics software to existing customers and new markets.